| abstract |
The present invention relates to pyrrolidine derivatives, providing compounds of formula I: , and pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, as well as pharmaceutical compositions containing them, are useful in the treatment or prevention of mGluR5-mediated disorders, such as acute and/or chronic neurological diseases, cognitive impairment and memory loss, and acute and chronic pain. |